Author:
Tan Xing-Yu,Aung Maung-Maung,Ngai Mei-Ing,Xie Feng,Ko Yu
Subject
Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)
Reference34 articles.
1. Assessing the economic burden of breast cancer in a US managed care population;Barron;Breast Cancer Res Treat,2008
2. The costs of breast cancer prior to and following diagnosis;Broekx;Eur J Health Econ,2011
3. Pharmacoeconomic considerations in the treatment of breast cancer;Pallis;Clinicoecon Outcomes Res,2010
4. Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality;Vera-Llonch;BMC Cancer,2011
5. Ministry of Health, Singapore, National Registry of Diseases Office. Interim annual registry report: trends in cancer incidence in Singapore 2006-2010. Available from: http://www.nrdo.gov.sg/uploadedFiles/NRDO/Cancer_Trends_Report_06-10_final2.pdf. [Accessed October 22, 2012].
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献